| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Medical Informatics [S. N.] and Pathology [C. J. M.], University of Utah School of Medicine, Salt Lake City, Utah 84132
BRCA1, a breast-ovarian cancer susceptibility gene which has been localized to 17q21, appears to be a tumor suppressor gene based on evidence from loss of heterozygosity (LOH) studies. We analyzed 14 ovarian and breast tumors from BRCA1 carriers and 1 sporadic breast tumor from 3 kindreds for 17q21 LOH. Thirteen of the 14 tumors from gene carriers exhibited LOH of the wild-type allele. Tumors from one gene carrier and the sporadic breast case did not exhibit any LOH in the region. There was loss of the wild-type allele from both maternally and paternally derived chromosomes, therefore excluding the possibility of genomic imprinting and providing further evidence that BRCA1 is a tumor suppressor. Three tumors showed interstitial LOH in the region, and thus established the utility of familial tumors in refining a region surrounding a tumor suppressor gene in a manner analogous to using genetic recombinants.
1 This work was supported by Grants CA-48711 and CA-55914 from the NIH.
2 To whom requests for reprints should be addressed, at Genetic Epidemiology, 420 Chipeta Way, Rm 180, Salt Lake City, UT 84108.
Received 8/31/94. Accepted 10/19/94.
This article has been cited by other articles:
![]() |
A. D. Spearman, K. Sweet, X.-P. Zhou, J. McLennan, F. J. Couch, and A. E. Toland Clinically Applicable Models to Characterize BRCA1 and BRCA2 Variants of Uncertain Significance J. Clin. Oncol., November 20, 2008; 26(33): 5393 - 5400. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Swisher, W. Sakai, B. Y. Karlan, K. Wurz, N. Urban, and T. Taniguchi Secondary BRCA1 Mutations in BRCA1-Mutated Ovarian Carcinomas with Platinum Resistance Cancer Res., April 15, 2008; 68(8): 2581 - 2586. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Meric-Bernstam Heterogenic Loss of BRCA in Breast Cancer: The "Two-Hit" Hypothesis Takes a Hit Ann. Surg. Oncol., September 1, 2007; 14(9): 2428 - 2429. [Full Text] [PDF] |
||||
![]() |
T. A. King, W. Li, E. Brogi, C. J. Yee, M. L. Gemignani, N. Olvera, D. A. Levine, L. Norton, M. E. Robson, K. Offit, et al. Heterogenic Loss of the Wild-Type BRCA Allele in Human Breast Tumorigenesis Ann. Surg. Oncol., September 1, 2007; 14(9): 2510 - 2518. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang and S. N. Powell The Role of the BRCA1 Tumor Suppressor in DNA Double-Strand Break Repair Mol. Cancer Res., October 1, 2005; 3(10): 531 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xiong, S. Fan, Q. Meng, L. Schramm, C. Wang, B. Bouzahza, J. Zhou, B. Zafonte, I. D. Goldberg, B. R. Haddad, et al. BRCA1 Inhibition of Telomerase Activity in Cultured Cells Mol. Cell. Biol., December 1, 2003; 23(23): 8668 - 8690. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Staff, J. Isola, and M. Tanner Haplo-insufficiency of BRCA1 in Sporadic Breast Cancer Cancer Res., August 15, 2003; 63(16): 4978 - 4983. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fan, Y. X. Ma, C. Wang, R.-Q. Yuan, Q. Meng, J.-A. Wang, M. Erdos, I. D. Goldberg, P. Webb, P. J. Kushner, et al. p300 Modulates the BRCA1 Inhibition of Estrogen Receptor Activity Cancer Res., January 1, 2002; 62(1): 141 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. MAGDINIER, L.-M. BILLARD, G. WITTMANN, L. FRAPPART, M. BENCHAÏB, G. M. LENOIR, J. F. GUÉRIN, and R. DANTE Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells FASEB J, August 1, 2000; 14(11): 1585 - 1594. [Abstract] [Full Text] |
||||
![]() |
T. K. MacLachlan, K. Somasundaram, M. Sgagias, Y. Shifman, R. J. Muschel, K. H. Cowan, and W. S. El-Deiry BRCA1 Effects on the Cell Cycle and the DNA Damage Response Are Linked to Altered Gene Expression J. Biol. Chem., January 28, 2000; 275(4): 2777 - 2785. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-C. Suen and P. E. Goss Transcription of BRCA1 Is Dependent on the Formation of a Specific Protein-DNA Complex on the Minimal BRCA1 Bi-directional Promoter J. Biol. Chem., October 29, 1999; 274(44): 31297 - 31304. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ruffner, W. Jiang, A. G. Craig, T. Hunter, and I. M. Verma BRCA1 Is Phosphorylated at Serine 1497 In Vivo at a Cyclin-Dependent Kinase 2 Phosphorylation Site Mol. Cell. Biol., July 1, 1999; 19(7): 4843 - 4854. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Cressman, D. C. Backlund, E. M. Hicks, L. C. Gowen, V. Godfrey, and B. H. Koller Mammary Tumor Formation in p53- and BRCA1-deficient Mice Cell Growth Differ., January 1, 1999; 10(1): 1 - 10. [Abstract] [Full Text] |
||||
![]() |
F. Durocher, J. Simard, J. Ouellette, V. Richard, F. Labrie, and G. Pelletier Localization of BRCA1 Gene Expression in Adult Cynomolgus Monkey Tissues J. Histochem. Cytochem., September 1, 1997; 45(9): 1173 - 1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Scully, S. F. Anderson, D. M. Chao, W. Wei, L. Ye, R. A. Young, D. M. Livingston, and J. D. Parvin BRCA1 is a component of the RNA polymerase II holoenzyme PNAS, May 27, 1997; 94(11): 5605 - 5610. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Ludwig, D L Chapman, V E Papaioannou, and A Efstratiadis Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes & Dev., May 15, 1997; 11(10): 1226 - 1241. [Abstract] [PDF] |
||||
![]() |
J. E. Thomas, M. Smith, B. Rubinfeld, M. Gutowski, R. P. Beckmann, and P. Polakis Subcellular Localization and Analysis of Apparent 180-kDa and 220-kDa Proteins of the Breast Cancer Susceptibility Gene, BRCA1 J. Biol. Chem., November 8, 1996; 271(45): 28630 - 28635. [Abstract] [Full Text] [PDF] |
||||
![]() |
T M Smith, M K Lee, C I Szabo, N Jerome, M McEuen, M Taylor, L Hood, and M C King Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res., November 1, 1996; 6(11): 1029 - 1049. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |